Annual Current Assets
$188.75 M
+$16.15 M+9.36%
December 31, 2022
Summary
- As of February 8, 2025, EGRX annual total current assets is $188.75 million, with the most recent change of +$16.15 million (+9.36%) on December 31, 2022.
- During the last 3 years, EGRX annual current assets has risen by +$9.30 million (+5.19%).
- EGRX annual current assets is now at all-time high.
Performance
EGRX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$187.25 M
-$5.24 M-2.72%
June 30, 2023
Summary
- As of February 8, 2025, EGRX quarterly total current assets is $187.25 million, with the most recent change of -$5.24 million (-2.72%) on June 30, 2023.
- Over the past year, EGRX quarterly current assets has dropped by -$7.21 million (-3.71%).
- EGRX quarterly current assets is now -32.05% below its all-time high of $275.57 million, reached on March 31, 2020.
Performance
EGRX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
EGRX Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.4% | -3.7% |
| 3 y3 years | +5.2% | +11.2% |
| 5 y5 years | +0.0% | -7.1% |
EGRX Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +9.4% | -22.0% | +8.5% |
| 5 y | 5-year | at high | +13.7% | -32.0% | +14.3% |
| alltime | all time | at high | +2029.2% | -32.0% | +1005.7% |
Eagle Pharmaceuticals Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $187.25 M(-2.7%) |
| Mar 2023 | - | $192.49 M(+2.0%) |
| Dec 2022 | $217.41 M(+168.0%) | $188.75 M(+2.0%) |
| Sep 2022 | - | $185.05 M(-4.8%) |
| Jun 2022 | - | $194.46 M(-19.0%) |
| Mar 2022 | - | $240.17 M(+39.1%) |
| Dec 2021 | $81.13 M(-6.9%) | $172.61 M(+0.5%) |
| Sep 2021 | - | $171.69 M(-2.2%) |
| Jun 2021 | - | $175.50 M(+7.0%) |
| Mar 2021 | - | $163.99 M(-1.3%) |
| Dec 2020 | $87.13 M(+16.0%) | $166.06 M(+1.4%) |
| Sep 2020 | - | $163.80 M(-2.8%) |
| Jun 2020 | - | $168.44 M(-38.9%) |
| Mar 2020 | - | $275.57 M(+53.6%) |
| Dec 2019 | $75.11 M(+0.5%) | $179.45 M(-0.2%) |
| Sep 2019 | - | $179.79 M(-3.2%) |
| Jun 2019 | - | $185.66 M(+1.9%) |
| Mar 2019 | - | $182.23 M(+11.2%) |
| Dec 2018 | $74.76 M | $163.84 M(-17.2%) |
| Sep 2018 | - | $197.77 M(-1.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $201.60 M(+19.4%) |
| Mar 2018 | - | $168.82 M(-10.5%) |
| Dec 2017 | $81.36 M(-22.7%) | $188.70 M(+3.6%) |
| Sep 2017 | - | $182.15 M(+47.1%) |
| Jun 2017 | - | $123.87 M(+0.2%) |
| Mar 2017 | - | $123.57 M(+13.3%) |
| Dec 2016 | $105.21 M(+4380.8%) | $109.11 M(-8.3%) |
| Sep 2016 | - | $119.05 M(-12.1%) |
| Jun 2016 | - | $135.50 M(+18.2%) |
| Mar 2016 | - | $114.62 M(-6.2%) |
| Dec 2015 | $2.35 M(+503.6%) | $122.26 M(+1.6%) |
| Sep 2015 | - | $120.30 M(-0.2%) |
| Jun 2015 | - | $120.55 M(-7.1%) |
| Mar 2015 | - | $129.79 M(+161.1%) |
| Dec 2014 | - | $49.71 M(-6.3%) |
| Sep 2014 | $389.00 K(-37.3%) | $53.02 M(-8.2%) |
| Jun 2014 | - | $57.76 M(-9.1%) |
| Mar 2014 | - | $63.53 M(+275.1%) |
| Dec 2013 | - | $16.94 M(-3.1%) |
| Sep 2013 | $620.00 K(+8.2%) | $17.48 M |
| Sep 2012 | $573.10 K | - |
FAQ
- What is Eagle Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals annual current assets year-on-year change?
- What is Eagle Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals quarterly current assets year-on-year change?
What is Eagle Pharmaceuticals annual total current assets?
The current annual current assets of EGRX is $188.75 M
What is the all time high annual current assets for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high annual total current assets is $188.75 M
What is Eagle Pharmaceuticals annual current assets year-on-year change?
Over the past year, EGRX annual total current assets has changed by +$16.15 M (+9.36%)
What is Eagle Pharmaceuticals quarterly total current assets?
The current quarterly current assets of EGRX is $187.25 M
What is the all time high quarterly current assets for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high quarterly total current assets is $275.57 M
What is Eagle Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, EGRX quarterly total current assets has changed by -$7.21 M (-3.71%)